Article metrics

Download PDFPDF

447 Interim results of a phase 1 study of the novel engineered toxin body TAK-169 in patients with relapsed or refractory multiple myeloma
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021322021
Dec 202110606
Jan 20224606
Feb 2022100013
Mar 202221007
Apr 202210806
May 202288012
Jun 20224406
Jul 20221803
Aug 20224000
Sep 202242012
Oct 20225007
Nov 20223804
Dec 202260014
Jan 20233004
Feb 20234405
Mar 20231802
Apr 20233207
May 20233601
Jun 20231603
Jul 202334010
Aug 202336010
Sep 202356010
Oct 20233803
Nov 20233604
Dec 20234602
Jan 20242600
Feb 20242003
Mar 20242003
Apr 20243807
May 20244805
Jun 20245207
Jul 20243203
Aug 20242003
Sep 202452017
Oct 20245009
Nov 20241803
Total20700238